Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK1 | Q13464 | 2/20 | 0.45 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.45 |
| ▸ | GUSB | P08236 | 2/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 9/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 9/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 4/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | DHODH | Q02127 | 1/20 | 0.38 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | EPOR | P19235 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6153683 | 0.81 | GUSB (0.51) | ROCK1ROCK2GUSBHDAC1HDAC2 | |
| SCHEMBL6154200 | 0.81 | GUSB (0.54) | ROCK1ROCK2GUSBS1PR1BLM | |
| SCHEMBL6153472 | 0.80 | GUSB (0.53) | ROCK1ROCK2GUSBHDAC6S1PR1 | |
| SCHEMBL6153725 | 0.79 | ROCK1 (0.42) | ROCK1ROCK2GUSBHDAC1HDAC2 | |
| SCHEMBL6153733 | 0.78 | ROCK1 (0.43) | ROCK1ROCK2GUSBHDAC1HDAC2 | |
| SCHEMBL6155142 | 0.78 | GUSB (0.60) | ROCK1ROCK2GUSBHDAC6BLM | |
| SCHEMBL6153810 | 0.78 | KMO (0.55) | ROCK1ROCK2GUSBHDAC1HDAC6 | |
| SCHEMBL6154359 | 0.77 | GUSB (0.65) | ROCK1ROCK2GUSBBLMDHODH | |
| SCHEMBL6154406 | 0.76 | MAPT (0.45) | ROCK1ROCK2GUSBKDM4EALDH1A1 | |
| SCHEMBL6154398 | 0.76 | MAPT (0.45) | ROCK1ROCK2GUSBKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050065118-A1 | Organosulfur inhibitors of tyrosine phosphatases | METABASIS THERAPEUTICS, INC. | 2005-03-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050065118-A1 | Organosulfur inhibitors of tyrosine phosphatases | PTPRS, PTPRJ, PTPRCAP | ROCK1 3290/4885ROCK2 3224/4885GUSB 2466/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.